| | Call Details | Mindray Medical International LTD Earnings Conference Call (Q3 2009) Tue,
Nov 10, 2009, 8:00 am Eastern
| | About Mindray Medical International LTD
(NYSE:MR) |
| | Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers patient monitoring devices for adult, pediatric, and neonatal patients, and used principally in hospital intensive care units, operating rooms, and emergency rooms. Its patient monitoring devices tracks the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. This segment provides single and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, an electro-cardiogram monitoring device, veterinary monitoring devices, and anesthesia machines. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. This segment also offers semi-automated and fully-automated in-vitro diagnostic products for laboratories, clinics, and hospitals. In addition, this segment provides hematology analyzers and biochemistry analyzers, and reagents. The Medical Imaging Systems segment sells portable and mobile ultrasound systems and digital radiography systems, and transducers. It sells its products to distributors, ODM and OEM customers, hospitals, and government agencies. The company has operations in North America, Europe, China, and other Asian countries. Mindray Medical International Limited was founded in 1991 and is headquartered in Shenzhen, the Peoples Republic of China. |
| More
Info:
Quote
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Financials |
|